HBLCX
Price
$14.75
Change
+$0.03 (+0.20%)
Updated
Oct 17 closing price
Net Assets
11.79B
JIAIX
Price
$9.54
Change
+$0.01 (+0.10%)
Updated
Oct 17 closing price
Net Assets
111.58M
Interact to see
Advertisement

HBLCX vs JIAIX

Header iconHBLCX vs JIAIX Comparison
Open Charts HBLCX vs JIAIXBanner chart's image
Hartford Balanced Income C
Price$14.75
Change+$0.03 (+0.20%)
VolumeN/A
Net Assets11.79B
JHancock Multi-Asset High Income I
Price$9.54
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets111.58M
HBLCX vs JIAIX Comparison Chart in %
View a ticker or compare two or three
VS
HBLCX vs. JIAIX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLCX is a Hold and JIAIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLCX has more cash in the bank: 11.8B vs. JIAIX (112M). JIAIX pays higher dividends than HBLCX: JIAIX (5.58) vs HBLCX (2.58). HBLCX was incepted earlier than JIAIX: HBLCX (19 years) vs JIAIX (11 years). HBLCX (1.64) is less costly to investors than JIAIX (0.81). HBLCX is a more actively managed with annual turnover of: 61.00 vs. JIAIX (46.00). HBLCX has a lower initial minimum investment than JIAIX: HBLCX (2000) vs JIAIX (250000). JIAIX annual gain was more profitable for investors over the last year : 8.66 vs. HBLCX (1.35). JIAIX return over 5 years is better than : 24.09 vs. HBLCX (11.49).
HBLCXJIAIXHBLCX / JIAIX
Total Expense Ratio1.640.69238%
Annual Report Gross Expense Ratio1.640.81202%
Fund Existence19 years11 years-
Gain YTD8.0899.66284%
Front LoadN/AN/A-
Min. Initial Investment20002500001%
Min. Initial Investment IRA2000N/A-
Net Assets11.8B112M10,536%
Annual Yield % from dividends2.585.5846%
Returns for 1 year1.358.6616%
Returns for 3 years21.2238.4255%
Returns for 5 years11.4924.0948%
Returns for 10 years35.2951.4669%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETNHX42.070.06
+0.14%
Eventide Healthcare & Life Sciences N
IJPTX12.35N/A
N/A
VY® JPMorgan Emerging Markets Equity S2
FZALX29.92N/A
N/A
Fidelity Advisor Mega Cap Stock Z
MSCUX11.42N/A
N/A
Morgan Stanley American Resilience A
AIOIX11.50-0.06
-0.52%
American Century International Opps Inv